Antithrombin Market by Source, Application and Geography. Market Leaders are Grifols, rEVO Biologics, Kedrion, CSL Limited, Scripps Laboratories, Lee Bisolutions, Dem ilac, Diapharma Group and Octapharma AG.

Precision Business Insights (PBI) in its report titled “Anti-thrombin Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the anti-thrombin market revenue growth over forecast period.

The anti-thrombin market size was accounted for US$ XX Mn in 2018 and anticipated to account for US$ XX Mn by 2025. Increasing incidence of coagulation disorders, open heart surgeries, and extracorporeal circulation during hemodialysis is augmenting growth of anti-thrombin market. According to the Centers for Disease Control and Prevention (CDC), 2015, around 900,000 people is affected from venous thromboembolism every year in the U.S. Therapeutic drug pipeline or advancements in drug administering technology is also expected to fuel growth of anti-thrombin market.

Furthermore, increasing use of anti-thrombin in combination with heparin is likely to support the growth of anti-thrombin market. For instance, heparin resistance in cardiac surgery is likely to create opportunities for use of anti-thrombin products in anticoagulation therapy. However, increasing regulations on animal testing have impeded a number of healthcare companies from manufacturing new drugs, thereby restraining the market growth.

Anti-thrombin market segmented on the basis of source, application, dosage form end user and regions.

Human Milk Source Segment Expected to Dominate the Market

Based on source, anti-thrombin market is as human, and goat milk. The human source, the segment is estimated to account major shares in global antithrombin market in 2017. Humans are the major source of anti-thrombin, but now a day’s goat milk became alternative for human source. Goats produce about 800 liters of milk per year. The yield of the active protein by goat model is 10X higher than cell culture model. The transgenic goats are the excellent source for antithrombin production, as they produce plenty of milk in short generation time, and these factors are responsible for the high growth of goat milk segment over the forecast period. Currently, the goat milk produced antithrombins are available in developed countries such as U.S., UK, and Germany. The increasing adoption of newer technologies and advanced products in developing countries is expected to drive the growth of segment over the forecast period.

Read more Insights at https://precisionbusinessinsights.com/market-reports/antithrombin-market/

North America, Accounts for Major Revenue Share for Anti-thrombin Market

Precision Business Insights (PBI) anti-thrombin market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North America is expected to gain significant traction in the global anti-thrombin market, followed by Europe, owing to adoption of robust developed technologies and antithrombin therapies, and high awareness and increasing regulatory approval of drugs in these regions.

Moreover, improving healthcare infrastructure in emerging economies such as China and India, and increasing research and development activities are contributing towards the growth of anti-thrombin market in Asia Pacific region.

New Product Launch & Innovations Play Vital Role in Anti-thrombin Market

Key players implement various strategies to establish their footprint in the global market, thereby enhancing their sale and outreaching the customers. For instance, in April 2014, Revo Biologics started preserve – 1 phase III clinical trials of ATryn (recombinant antithrombin) for treatment of preeclampsia in pregnant women during 24th to 28th weeks of pregnancy.
Key player’s profiles in the report areGrifols, Shire Plc., rEVO Biologics Inc., CSL Limited, Kedrion S.p.A, Lee Bisolutions, Scripps Laboratories Inc., GTC Biotherapeutics, Inc.’s, Green Cross Corp., and BDI Pharma, and among others.

Download free sample report at https://precisionbusinessinsights.com/request-sample?product_id=19020

Detailed Segmentation

By Source Type

o Goat Milk
o Human
o Others

By Application Type

o Diagnostics
o Therapeutics
o Research

By Dosage Form

o Liquid
o Lyophilized

By End-User Type

o Blood Banks
o Diagnostic Centres
o Hospitals

Geography

o North America
 U.S.
 Canada
o Europe
 Germany
 UK
 France
 Russia
 Spain
 Italy
 Rest of Europe
o Asia-Pacific
 China
 Japan
 India
 ASEAN
 Rest of Asia Pacific
o Latin America
 Brazil
 Mexico
 Argentina
 Chile
 Rest of Latin America
o Middle East and Africa
 South Africa
 Gulf Corporation Council Countries(GCC)
 Rest of MEA

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

This release was published on openPR.